Stock listing
CTSO Stock Price, News, Filings & Events — Cytosorbents Corporation
Selected listing: CTSO · NASDAQ · USD · US
This page tracks Cytosorbents Corporation's CTSO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTSO:NASDAQ. CTSO:NASDAQ is the stock-level entry point for investors researching Cytosorbents Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytosorbents Corporation, trading under the ticker CTSO, is a public company based in America with a market capitalization of approximately $22.6 million. The company focuses on developing innovative therapies to treat critical illnesses using its proprietary blood purification technology. Cytosorbents aims to improve patient outcomes through its advanced medical solutions.
- Ticker
- CTSO:NASDAQ
- Asset type
- Stock
- Market cap
- $21.1M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Cytosorbents Corporation CTSO:NASDAQ stock context
This page tracks Cytosorbents Corporation's CTSO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CTSO:NASDAQ. CTSO:NASDAQ is the stock-level entry point for investors researching Cytosorbents Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cytosorbents Corporation, trading under the ticker CTSO, is a public company based in America with a market capitalization of approximately $22.6 million. The company focuses on developing innovative therapies to treat critical illnesses using its proprietary blood purification technology. Cytosorbents aims to improve patient outcomes through its advanced medical solutions.
Latest news from Cytosorbents Corporation
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
July 20, 2026
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
June 18, 2026
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
May 13, 2026
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
April 30, 2026
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 25, 2026
Cytosorbents Corporation earnings calls
Cytosorbents Corporation (CTSO) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Cytosorbents Corporation (CTSO) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call
March 25, 2026 · Replay with transcript and chapters
Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Cytosorbents Corporation (CTSO) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Cytosorbents Corporation (CTSO) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
Research Cytosorbents Corporation
Cytosorbents Corporation investor report
Review AI stock analysis and investor report context for CTSO:NASDAQ.
Cytosorbents Corporation company profile
View the public company page for Cytosorbents Corporation on 6ix.
Cytosorbents Corporation news
Read company news and market updates connected to Cytosorbents Corporation.
Cytosorbents Corporation investor events
Find investor webinars, events, and replay context for Cytosorbents Corporation.
Alternate listings
HQE1:GETTEX
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
A12GDU:LSX
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
A12GDU:LS
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
CTSO:BOATS
US · USD
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
HQE1:TRADEGATE
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
HQE1:BX
CH · CHF
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
HQE1:DUS
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
HQE1:FWB
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
HQE1:MUN
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.
HQE1:SWB
DE · EUR
Alternate listing for Cytosorbents Corporation; the primary context on this page is CTSO:NASDAQ.